UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000024477 |
|---|---|
| Receipt number | R000028062 |
| Scientific Title | Phase II trial of pertuzumab and trastuzumab in combination with S-1 for patients with HER2-positive metastatic breast cancer |
| Date of disclosure of the study information | 2016/10/19 |
| Last modified on | 2021/04/23 21:54:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/10/19 08:27:11 | ||
| 2 | Update | 2016/10/19 08:41:07 | UMIN ID1 UMIN ID2 |
|
| 3 | Update | 2019/01/08 18:38:36 | Recruitment status |
|
| 4 | Update | 2021/04/23 21:54:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Department Division Nationality of Funding Organization Co-sponsor Name of secondary funder(s) Email3 Organization Organization Address Address Tel Institutions |
